Abeona Therapeutics logo

Abeona Therapeutics Share Price Today

(NASDAQ: ABEO)

Abeona Therapeutics share price is $5.78 & ₹501.28 as on 22 Feb 2025, 2.30 'hrs' IST

$5.78

-0.04

(-0.69%)

Market is closed - opens 8 PM, 24 Feb 2025

View live Abeona Therapeutics share price in Dollar and Rupees. Guide to invest in Abeona Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Abeona Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Abeona Therapeutics share price movements

  • Today's Low: $5.77
    Today's High: $5.90

    Day's Volatility :2.12%

  • 52 Weeks Low: $3.05
    52 Weeks High: $9.01

    52 Weeks Volatility :66.15%

Abeona Therapeutics (ABEO) Returns

PeriodAbeona Therapeutics Inc.Russel 2000Index (Russel 2000)
3 Months
-2.02%
0.0%
0.0%
6 Months
1.39%
0.0%
0.0%
1 Year
-16.62%
0.0%
0.0%
3 Years
1.04%
-12.0%
-12.0%

Abeona Therapeutics (ABEO) Key Statistics

in dollars & INR

Previous Close
$5.82
Open
$5.86
Today's High
$5.8951
Today's Low
$5.77
Market Capitalization
$255.5M
Today's Volume
$180.1K
52 Week High
$9.01
52 Week Low
$3.05
Revenue TTM
$0.0
EBITDA
$-58.8M
Earnings Per Share (EPS)
$-2.05
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-209.5%

How to invest in Abeona Therapeutics Stock (ABEO) from India?

It is very easy for Indian residents to invest directly in Abeona Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Abeona Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Abeona Therapeutics or ABEO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Abeona Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Abeona Therapeutics shares which would translate to 0.150 fractional shares of Abeona Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Abeona Therapeutics, in just a few clicks!

Returns in Abeona Therapeutics (ABEO) for Indian investors in Rupees

The Abeona Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Abeona Therapeutics investment value today

Current value as on today

₹87,445

Returns

₹12,555

(-12.56%)

Returns from Abeona Therapeutics Stock

₹17,192 (-17.19%)

Dollar Returns

₹4,637 (+4.64%)

Indian investors sentiment towards Abeona Therapeutics (ABEO)

175%

Period: Jan 22, 2025 to Feb 21, 2025. Change in 30 Days versus previous period

Search interest for Abeona Therapeutics Stock from India on INDmoney has increased by 175% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Abeona Therapeutics

  • Suvretta Capital Management, LLC

    8.48%

  • Nantahala Capital Management, LLC

    7.90%

  • Adage Capital Partners Gp LLC

    7.48%

  • Millennium Management LLC

    5.29%

  • Vanguard Group Inc

    4.52%

  • Vivo Capital, LLC

    4.24%

Analyst Recommendation on Abeona Therapeutics

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Abeona Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Abeona Therapeutics Stock (ABEO)

What analysts predicted

Upside of 175.09%

Target:

$15.90

Current:

$5.78

Insights on Abeona Therapeutics Stock (Ticker Symbol: ABEO)

  • Price Movement

    In the last 1 month, ABEO stock has moved up by 12.1%
  • ABEO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.2% return, outperforming this stock by 76.0%
  • ABEO vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 70.2% return, outperforming this stock by 71.6%

Abeona Therapeutics Technicals Summary

Sell

Neutral

Buy

Abeona Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Abeona Therapeutics (ABEO) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Abeona Therapeutics Inc. logo
10.86%
1.39%
-16.62%
1.04%
-94.05%
Biontech Se logo
2.35%
34.7%
25.44%
-16.49%
285.23%
Regeneron Pharmaceuticals, Inc. logo
2.35%
-41.97%
-29.06%
14.29%
63.62%
Vertex Pharmaceuticals Incorporated logo
12.23%
-0.48%
11.68%
108.21%
102.66%
Alnylam Pharmaceuticals, Inc. logo
-5.83%
-6.74%
59.21%
70.2%
105.25%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Abeona Therapeutics Inc. logo
0.06
NA
0.0
-1.56
-2.1
-0.41
NA
1.06
Biontech Se logo
160.8
NA
0.04
-3.29
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.89
17.89
1.01
43.09
0.16
0.07
NA
273.57
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.3
18.11
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.59
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Abeona Therapeutics Inc. logo
Buy
$255.5M
-94.05%
0.06
0.0%
Biontech Se logo
Buy
$28.7B
285.23%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$75.0B
63.62%
17.89
31.07%
Vertex Pharmaceuticals Incorporated logo
Buy
$121.1B
102.66%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$32.4B
105.25%
NA
-12.37%

About Abeona Therapeutics

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.
Organization
Abeona Therapeutics
Employees
84
CEO
Dr. Vishwas Seshadri M.B.A., Ph.D.
Industry
Health Technology

Management People of Abeona Therapeutics

NameTitle
Dr. Vishwas Seshadri M.B.A., Ph.D.
President, CEO & Director
Mr. Joseph Walter Vazzano CPA
Chief Financial Officer
Dr. Brendan M. O'Malley J.D., Ph.D.
Chief Legal Officer
Mr. Brian Kevany Ph.D.
Senior VP, CTO & CSO
Mr. Gregory Gin
Vice President of Investor Relations & Corporate Communications
Ms. Alison Hardgrove
Chief People Officer
Mr. Jon Voss
VP & Head of Quality
Dr. Madhav Vasanthavada M.B.A., Ph.D.
Senior VP, Chief Commercial Officer & Head of Business Development
Mr. Carl Denny
Senior Vice President of Regulatory Affairs

Important FAQs about investing in ABEO Stock from India :

What is Abeona Therapeutics share price today?

Abeona Therapeutics share price today stands at $5.78, Open: $5.86 ; Previous Close: $5.82 ; High: $5.90 ; Low: $5.77 ; 52 Week High: $9.01 ; 52 Week Low: $3.05.

The stock opens at $5.86, after a previous close of $5.82. The stock reached a daily high of $5.90 and a low of $5.77, with a 52-week high of $9.01 and a 52-week low of $3.05.

Can Indians buy Abeona Therapeutics shares?

Yes, Indians can invest in the Abeona Therapeutics (ABEO) from India.

With INDmoney, you can buy Abeona Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Abeona Therapeutics at zero transaction cost.

How can I buy Abeona Therapeutics shares from India?

It is very easy to buy Abeona Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Abeona Therapeutics (ABEO) be purchased?

Yes, you can buy fractional shares of Abeona Therapeutics with INDmoney app.

What are the documents required to start investing in Abeona Therapeutics stocks?

To start investing in Abeona Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Abeona Therapeutics Stock (ABEO)?

Today’s highest price of Abeona Therapeutics (ABEO) is $5.90.

Today’s lowest price of Abeona Therapeutics (ABEO) is $5.77.

What is today's market capitalisation of Abeona Therapeutics?

Today's market capitalisation of Abeona Therapeutics ABEO is 255.5M

What is the 52 Week High and Low Range of Abeona Therapeutics Stock (ABEO)?

  • 52 Week High

    $9.01

  • 52 Week Low

    $3.05

What are the historical returns of Abeona Therapeutics (ABEO)?

  • 1 Month Returns

    10.86%

  • 3 Months Returns

    1.39%

  • 1 Year Returns

    -16.62%

  • 5 Years Returns

    -94.05%

Who is the Chief Executive Officer (CEO) of Abeona Therapeutics ?

Dr. Vishwas Seshadri M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Abeona Therapeutics.